Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2026-03-11 @ 7:35 AM
Study NCT ID:
NCT01743651
Status:
COMPLETED
Last Update Posted:
2022-04-25
First Post:
2012-11-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
Sponsor:
RVL Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11
Start Date Type:
None
Primary Completion Date:
2014-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-11-28
First Submit QC Date:
None
Study First Post Date:
2012-12-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-05-11
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-04-21
Last Update Post Date:
2022-04-25
Last Update Post Date Type:
ACTUAL